<i>NTRK</i> Fusion in a Cohort of <i>BRAF p. V600E</i> Wild-Type Papillary Thyroid Carcinomas

Citations

WEB OF SCIENCE

10
Citations

SCOPUS

14

초록

Owing to the availability of a potent tropomyosin receptor kinase (TRK) inhibitor, it is necessary to develop an effective strategy to identify an enriched population of NTRK fusions in papillary thyroid carcinoma (PTC) in routine diagnostic practice. The reported prevalence of NTRK fusion in a large cohort of PTC is similar to 3%. We performed an analysis to refine the characteristic histologic features of PTCs harboring NTRK fusions and further validate the diagnostic utility of pan-TRK immunohistochemistry as a screening tool. In this study, 450 PTCs known to harbor no BRAF p. V600E mutations were screened by pan-TRK immunohistochemistry, and the cases with TRK expression were confirmed by RNA-based next-generation sequencing assay. Eleven NTRK fusion cases were detected (2.4%), and all PTCs were classical subtypes. NTRK1 and NTRK3 were involved in the fusion with 9 different partner genes. Most cases showed similar characteristic histologic findings. Nodular permeative border, multinodular growth with a predominantly follicular pattern, extensive lymphatic invasion, and prominent internodular and intratumoral fibrosis were the characteristic histologic features of NTRK-rearranged PTCs. The ill-defined margins in the ultrasonography findings, which could not be clearly distinguished from the adjacent nontumorous thyroid tissue, were nodular permeative margins in histologic findings. Therefore, preoperative ultrasonographic findings in nodule margins were consistent with the final histologic findings. NTRK1/3 fusion in PTCs showed an overall sensitivity of 100% (95% CI, 71.51%-100%) and specificity of 100% (95% CI, 71.51%-10 0%) in the 22 cases examined, as confirmed with next-generation sequencing. Our study provides an integrative report of the preoperative ultrasonographic, histologic, immunohistochemical, and molecular features of NTRK-rearranged PTCs. Based on these findings, we propose an algorithmic approach for the stepwise assessment of NTRK fusions in PTCs.(c) 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.

키워드

NTRK fusion; pan-TRK immunohistochemistry; papillary thyroid carcinoma (PTC); TRK inhibitors; RNA-based NGS assay; HIGH PREVALENCE; ONCOGENES; LANDSCAPE; EFFICACY
제목
<i>NTRK</i> Fusion in a Cohort of <i>BRAF p. V600E</i> Wild-Type Papillary Thyroid Carcinomas
저자
Lee, Seung Eun; Lee, Mi-Sook; Bang, Heejin; Kim, Mi Young; Choi, Yoon-La; Oh, Young Lyun
DOI
10.1016/j.modpat.2023.100180
발행일
2023-08
유형
Article
저널명
Modern Pathology
권
36
호
8